US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Prime Medicine, Inc. - Common Stock (NQ:PRME)

3.500 +0.290 (+9.03%)
Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prime Medicine, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Ryanair Holdings, Prime Medicine And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
DISH Network, Goodyear And 3 Stocks To Watch Heading Into Monday ↗
With U.S. stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Efficient Ability of Prime Editors to Precisely Correct Disease-causing Mutation of GSD1b
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Analyst Ratings for Prime Medicine ↗
 
Via Benzinga
News headline image
2 Cathie Wood Stocks That Could Be Hidden Gems ↗
These two biotech stocks could deliver life-altering returns for long-term investors. 
Via The Motley Fool
News headline image
Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of Prime Editors to Treat Ophthalmological Diseases
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
7 Biotech Stocks to Get In Now Before Investors Catch On ↗
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them. 
Via InvestorPlace
News headline image
Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Platform at Upcoming Industry Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Preclinical-Phase Firm Prime Medicine's Gene Editing Platform Has Potential: Analyst ↗
BMO Capital Markets has initiated coverage on Prime Medicine Inc (NASDAQ: PRME), a preclinical-stage company focused on developing therapies based on prime editing. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023 ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 369 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 386 stocks made new 52-week lows. 
Via Benzinga
News headline image
Prime Medicine to Present at Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗
 
Via Benzinga
News headline image
Prime Medicine to Present at Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs™ for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought ↗
There are always stocks to buy if you're Ark Invest's ace stock picker. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗
 
Via Benzinga
News headline image
Prime Medicine to Present at Investor Conferences in June
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
There are always stocks to buy if you're Ark Invest's ace stock picker. 
Via The Motley Fool
News headline image
Prime Medicine to Present at Virtual Investor Conferences in May
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023 ↗
 
Via Benzinga
News headline image
Prime Medicine to Present at Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at Cowen 43rd Annual Health Care Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
10 Short Squeeze Candidates: Getty Images, Genius Brands, MicroStrategy And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >